Literature DB >> 30779099

Influence of lncRNA MALAT1 on septic lung injury in mice through p38 MAPK/p65 NF-κB pathway.

L-P Lin1, G-H Niu, X-Q Zhang.   

Abstract

OBJECTIVE: To investigate the influence of long non-coding ribonucleic acid (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) on septic lung injury in mice and its mechanism, so as to provide references for the clinical prevention and treatment of septic lung injury in the future.
MATERIALS AND METHODS: A total of 60 male C57 mice were randomly divided into Control group (n=20), lipopolysaccharide (LPS) group (n=20), and LPS+MALAT1 siRNA group (n=20) using a random number table. The mouse model of septic lung injury was established via intraperitoneal injection of LPS (10 mg/kg), and the MALAT1 knockdown model was established via tail intravenous injection of MALAT1 siRNA. After 12 h, the lung was taken to measure the wet weight/dry weight ratio. Also, the activity of myeloperoxidase (MPO) in lung tissues was detected. The number of neutrophils and macrophages in bronchoalveolar lavage fluid (BALF) was detected via bronchoalveolar lavage. Moreover, the messenger RNA (mRNA) expression levels of inflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1), and IL-6, in lung tissues were detected via Reverse Transcription-Polymerase Chain Reaction (RT-PCR). Finally, the expression level of p38 in lung tissues was detected via immunohistochemical staining, and the expressions of p38 mitogen-activated protein kinase (MAPK)/p65 nuclear factor-κB (NF-κB) signaling pathway-related proteins in lung tissues of mice were detected via Western blotting.
RESULTS: The expression of lncRNA MALAT1 in lung tissues of mice with septic lung injury was significantly increased (p<0.05). After knockdown of lncRNA MALAT1, the LPS-induced pathological injury of lungs could be improved, and the wet weight/dry weight ratio of lungs could be reduced (p<0.05). Compared with those in LPS group, the total number of inflammatory cells and the number of neutrophils and macrophages in BALF were significantly decreased in LPS+MALAT1 siRNA group (p<0.05), and the levels of inflammatory cytokines were also significantly inhibited (p<0.05). The immunohistochemical results manifested that the knockdown of lncRNA MALAT1 could inhibit the LPS-induced up-regulation of p38 in lung tissues in mice. According to the results of Western blotting, the p38 MAPK/p65 NF-κB signaling pathway was significantly activated in lung tissues in LPS group (p<0.05), while it was significantly suppressed after inhibition on lncRNA MALAT1 (p<0.05).
CONCLUSIONS: The knockdown of lncRNA MALAT1 can significantly improve the septic lung injury in mice, whose mechanism may be related to its inhibition on the p38 MAPK/p65 NF-κB signaling pathway.

Entities:  

Year:  2019        PMID: 30779099     DOI: 10.26355/eurrev_201902_17025

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  15 in total

Review 1.  Long non-coding RNA (lncRNA): A potential therapeutic target in acute lung injury.

Authors:  Almaz Zaki; M Shadab Ali; Vijay Hadda; Syed Mansoor Ali; Anita Chopra; Tasneem Fatma
Journal:  Genes Dis       Date:  2021-08-14

2.  Knockdown of lncRNA MALAT1 Alleviates LPS-Induced Acute Lung Injury via Inhibiting Apoptosis Through the miR-194-5p/FOXP2 Axis.

Authors:  Chuan-Chuan Nan; Ning Zhang; Kenneth C P Cheung; Hua-Dong Zhang; Wei Li; Cheng-Ying Hong; Huai-Sheng Chen; Xue-Yan Liu; Nan Li; Lixin Cheng
Journal:  Front Cell Dev Biol       Date:  2020-10-07

3.  Potential role of circulating long noncoding RNA MALAT1 in predicting disease risk, severity, and patients' survival in sepsis.

Authors:  Feng Geng; Wei Liu; Li Yu
Journal:  J Clin Lab Anal       Date:  2019-07-13       Impact factor: 2.352

4.  Integrated Analysis of a Gene Correlation Network Identifies Critical Regulation of Fibrosis by lncRNAs and TFs in Idiopathic Pulmonary Fibrosis.

Authors:  Fan Wang; Pei Li; Feng-Sen Li
Journal:  Biomed Res Int       Date:  2020-06-02       Impact factor: 3.411

5.  The clinical value of lncRNA MALAT1 and its targets miR-125b, miR-133, miR-146a, and miR-203 for predicting disease progression in chronic obstructive pulmonary disease patients.

Authors:  Shuang Liu; Min Liu; Lixia Dong
Journal:  J Clin Lab Anal       Date:  2020-06-25       Impact factor: 2.352

Review 6.  Non-coding RNAs as Regulators of Cellular Senescence in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Norihito Omote; Maor Sauler
Journal:  Front Med (Lausanne)       Date:  2020-12-23

Review 7.  Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis.

Authors:  Chuqiao Wang; Guorui Liang; Jieni Shen; Haifan Kong; Donghong Wu; Jinxiang Huang; Xuefeng Li
Journal:  Front Immunol       Date:  2021-09-22       Impact factor: 7.561

8.  Chronic Intermittent Hypoxia Reduces the Effects of Glucosteroid in Asthma via Activating the p38 MAPK Signaling Pathway.

Authors:  Li Liang; Xin Gu; Hai Ji Shen; Yu Heng Shi; Yao Li; Jie Zhang; Yan Yan Chen; Zhen He Chen; Jia Yun Ma; Qing Yun Li
Journal:  Front Physiol       Date:  2021-08-27       Impact factor: 4.566

9.  Down-regulation of SNHG16 alleviates the acute lung injury in sepsis rats through miR-128-3p/HMGB3 axis.

Authors:  Junli Sun; Keke Xin; Chenghui Leng; Jianlin Ge
Journal:  BMC Pulm Med       Date:  2021-06-06       Impact factor: 3.317

10.  Propofol attenuates lung ischemia/reperfusion injury though the involvement of the MALAT1/microRNA-144/GSK3β axis.

Authors:  Jian-Ping Zhang; Wei-Jing Zhang; Miao Yang; Hua Fang
Journal:  Mol Med       Date:  2021-07-15       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.